Author

S. Uppal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:metagenomics· 1

Frequent Co-Authors

A. Bhatia· 1 shared A. Dey· 1 shared D. Xu· 1 shared G. Wang· 1 shared H. S. Misra· 1 shared J. C. Kwan· 1 shared J. L. Metz· 1 shared K. Kaur· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bhatia

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Uncovering Lasonolide A biosynthesis using genome-resolved metagenomics

S. Uppal, J. L. Metz, R. K. M. Xavier, K. Nepal, D. Xu, G. Wang, J. C. Kwan

This paper identifies the biosynthetic pathway for lasonolide A in a marine sponge-associated bacterium using genome-resolved metagenomics.

bioRxiv · May 23, 2022Microbiology

RNase H1 exists as phase-separated assemblies in association with elongating RNA Polymerase II during transcription

R. Das, A. Dey, H. S. Misra, S. Uppal

The paper shows RNase H1 forms phase-separated assemblies with RNA Polymerase II during transcription, regulating R-loop levels through liquid-liquid phase separation.

bioRxiv · Apr 8, 2022 · PreprintCell Biology

Synthesis, Physiochemical and Biological evaluation of Inclusion Complex of Benzyl Isothiocyanate encapsulated in cyclodextrins for triple negative breast cancer

S. Uppal, R. Kumar, K. Kaur, S. Sareen, A. Bhatia, S. K. Mehta

This study evaluates BITC-CD complexes for triple-negative breast cancer treatment, showing enhanced bioavailability and ROS-mediated cell death.

bioRxiv · Feb 14, 2021 · PreprintCancer Biology